I think some investors just read 'complete repsonses' and YOLO'd in in a hurry.
When everyone had time to digest the news, it was clear that it wasn't a huge announcement. Good, but some downsides.
Sure, 3 complete responses and cohort B looking promising. But Azer-Cel already had 39 complete responses from 84 patients in previous trials, so not earth shattering news.
The downside is that the phase 1b is taking longer than expected and the start of the registrational phase2/3 trial is probably 12 months behind schedule, maybe beginning 2026.
So good, not earth shattering, and some disappointment included.
Media Thread, page-15381
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.0¢ | 4.8¢ | $519.1K | 10.60M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 70 | 9859318 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 316611 | 5 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |